共 2 条
Leitlinienempfehlungen für den klinischen Alltag: die 2023-ESC-Leitlinien zum Management kardiovaskulärer Erkrankungen bei Diabetes mellitus
被引:0
作者:
Marx, Nikolaus
[1
]
Roden, Michael
[2
,3
]
Kelm, Malte
[4
]
Grandoch, Maria
[5
]
机构:
[1] Uniklin RWTH Aachen, Klin Kardiol Pneumol Angiol & Internist Intensivme, Med Klin 1, Pauwelsstr 30, D-52074 Aachen, Germany
[2] Heinrich Heine Univ, Klin Endokrinol Diabetol, Med Fak, Dusseldorf, Germany
[3] Heinrich Heine Univ, Univ Klinikum, Dusseldorf, Germany
[4] Univ klinikum Dusseldorf, Klin Kardiol Pneumol & Angiol, Dusseldorf, Germany
[5] Heinrich Heine Univ, Inst Translat Pharmakol, Dusseldorf, Germany
关键词:
diabetes;
cardiovascular disease;
heart failure;
chronic kidney disease;
D O I:
10.1055/a-2317-4526
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Patients with diabetes exhibit an increased risk to develop cardiovascular disease and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based therapeutic strategies to reduce cardiovascular risk. The new 2023 ESC Guidelines provide clear recommendations for the management of cardiovascular disease in patients with diabetes. The most relevant aspects are summarized in the following overview article.
引用
收藏
页码:302 / 307
页数:6
相关论文